These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8677322)

  • 1. [Cost-benefit analysis in mammography screening].
    von Fournier D
    Radiologe; 1996 Apr; 36(4):300-5. PubMed ID: 8677322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mammography screening in Germany].
    Diekmann S; Diekmann F
    Radiologe; 2008 Jan; 48(1):17-25. PubMed ID: 18030441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
    Warmerdam PG; de Koning HJ; Boer R; Beemsterboer PM; Dierks ML; Swart E; Robra BP
    J Epidemiol Community Health; 1997 Apr; 51(2):180-6. PubMed ID: 9196649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.
    de Koning HJ; van Ineveld BM; van Oortmarssen GJ; de Haes JC; Collette HJ; Hendriks JH; van der Maas PJ
    Int J Cancer; 1991 Oct; 49(4):531-7. PubMed ID: 1917154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening mammography and public health policy: the need for perspective.
    Wright CJ; Mueller CB
    Lancet; 1995 Jul; 346(8966):29-32. PubMed ID: 7603143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk- and cost-benefit analyses of breast screening programs derived from absorbed dose measurements in The Netherlands.
    Zuur C; Broerse JJ
    Diagn Imaging Clin Med; 1985; 54(3-4):211-22. PubMed ID: 3928229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-oriented mass mammography screening.
    Burhenne LJ; Burhenne HJ; Kan L
    Radiology; 1995 Jan; 194(1):185-8. PubMed ID: 7997549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
    Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
    Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective cost-effectiveness analysis of screening mammography.
    Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
    J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the benefits and costs of screening mammograms on Kentucky women aged 40-49?
    Spratt JS; Gaines BM; Aaron WS; Cerrito P
    J Surg Oncol; 1996 Oct; 63(2):71-6. PubMed ID: 8888797
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.